Epidemiologic Characteristics of Children with Blood Lead Levels ≥45 μg/dL

Brett Keller1, Andrew Faciano1, Adey Tsega1

  • 1New York City Department of Health and Mental Hygiene, New York, NY.

The Journal of Pediatrics
|October 25, 2016
PubMed

Insights

Severe childhood lead poisoning in NYC is linked to specific risk factors like eating paint or soil, and international travel. Early identification and intervention are crucial for affected children.

Area of Science:

  • Pediatric Environmental Health
  • Toxicology
  • Public Health Policy

Background:

  • Childhood lead poisoning remains a significant public health concern, despite declining incidence.
  • Severe blood lead levels (BLLs) in children necessitate identification of risk factors and outcomes.
  • Understanding these factors informs clinical practice and public health interventions.

Purpose of the Study:

  • To identify risk factors for children with newly diagnosed blood lead levels (BLLs) ≥45 µg/dL in New York City (NYC).
  • To describe the outcomes for these children during 2004-2010.
  • To promote timely identification and inform clinical and public health policies.

Main Methods:

  • Retrospective case series of 145 children in NYC with BLLs ≥45 µg/dL.
  • Inclusion criteria: NYC residence and confirmatory venous BLL within 2 weeks of initial elevated BLL.
  • Data linkage included case coordination, blood testing, and home inspection reports; comparison with NYC general child population.

Main Results:

  • Major risk factors identified: eating paint (36%), international travel (34%), developmental delay (27%), imported products (26%), foreign-born status (14%), Pakistani descent (12%), eating soil (5%), and sickle cell disease (4%).
  • Children with severe BLLs were more likely to be Asian or black and reside in pre-1940 housing compared to the general NYC child population.
  • Median time for BLL to decline below 10 µg/dL was 3.26 years.

Conclusions:

  • Severe lead poisoning cases still occur, requiring physician vigilance.
  • At-risk populations include children ingesting paint/soil, traveling internationally (especially Pakistan), using imported products, or with developmental delays/sickle cell disease.
  • Timely identification and targeted interventions are critical for managing severe childhood lead exposure.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.9K